SCHEMBL21341405

SCHEMBL21341405

CC(C)c1cc2ccc(C(C)(C)C)c(F)c2n1COP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24944145 0.77 EIF4A3 (0.33) —
SCHEMBL24630673 0.72 — —
SCHEMBL21341470 0.61 HDAC10 (0.39) —
SCHEMBL31265044 0.60 PGR (0.43) —
SCHEMBL21341402 0.59 CFTR (0.37) —
SCHEMBL21341404 0.59 KDM4E (0.30) —
SCHEMBL24944146 0.59 — —
SCHEMBL12755272 0.58 CDK4 (0.31) —
SCHEMBL24148517 0.57 — —
SCHEMBL24630643 0.57 CASR (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130749-B2 — — 2021-09-28 — — US disclosed
US-20190276440-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) 2019-09-12 — — US disclosed
Send feedback